You are here

Article Text

Article menu
Download PDFPDF
Letter
Tofacitinib for the treatment of antineutrophil cytoplasm antibody-associated vasculitis: a pilot study

https://doi.org/10.1136/annrheumdis-2021-220484

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors YL participated in data collection and patient follow-up and wrote the manuscript. ZJ, WY and SW helped in patient data collection at baseline and follow-up. HC, LM and ZD helped with patient follow up. LJ contributed to the study design and manuscript revision.

    • Funding This work was supported by the National Natural Science Foundation of China (numbers 81800541, 81801598 and 81771730) and the Shanghai Shen Kang Hospital Development Centre Clinical Cultivation Project (SHDC12019X05).

    • Competing interests None declared.

    • Patient and public involvement Patients and the public were not involved in the design, conduct, reporting or dissemination plans of this research.

    • Provenance and peer review Not commissioned; externally peer reviewed.